Healthcare technology provider Quantros announced earlier today that it has received an investment from Ascension Health Ventures (AHV). The company did not elaborate as to the specific amount received from the healthcare venture capital fund. Following the deal, AHV investment director Victor Kats joined the software company's board of directors.

The proceeds gained from the deal with AHV will be used to finance the development of Quantros' product portfolio. This includes Quantro's latest breakthrough, Smart Classification, the first clinically intuitive program that allows quick and efficient classification of safety-related incident reports in real-time.

"This is terrific recognition of our success as a leader in the quality, safety and risk management areas," shared Quantros Chief Executive Officer and President Keith Hagen. "We are thrilled to expand the industry expertise of our Board and use this partnership with AHV to advance into broader areas of the healthcare market."

Quantros, with established headquarters in Milpitas, California, develops and provides efficient intelligence solutions to the healthcare sector.